Skip to main content

Advertisement

Log in

The Clinical Significance of 25OH-Vitamin D Status in Celiac Disease

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Reduced bone mineral density is frequently found especially in adult celiac disease (CD) and dietary guidelines favor vitamin D supplementation in adults and children with CD. Vitamin D serum levels were investigated in CD populations in order to challenge its routine supplementation. Israeli (61), Spanish (59), CD children (groups 1 and 5, respectively) were compared to children with nonspecific abdominal pain (56), their parents (84) and Spanish adult CD patients (22) (group 2, 3, 4, respectively). 25(OH)-vitamin D was checked by LIAISON chemiluminescent immunoassays. Groups 5 and 1 had the highest levels compared to groups 4 and 3 with the lowest levels. The levels in groups 1 and 2 were comparable. Concerning 25(OH)-vitamin D sera levels, only the difference between group 5 and 4 was statistically significant (30.3 ± 12.3 and 20.2 ± 10.5 ng/ml, respectively p = 0.003). When vitamin D was splitted above and below 20 ng/ml level, 54.5% of Spanish adult CD had vitamin D deficiency compared to 16.9% of the local CD children (p = 0.001). 29.6% of group 2 had deficient levels compared to their parents with 50% (p = 0.019). In conclusion, Vitamin D sera levels negatively correlate with age. Thus, mainly adult CD population should be assessed for vitamin D levels and supplemented accordingly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lerner A, Blank M, Shoenfeld Y (1996) Celiac disease and autoimmunity. Isr J Med Sci 32:33–36

    PubMed  CAS  Google Scholar 

  2. Reif S, Lerner A (2004) Celiac disease and infection. In: infections and Autoimmunity. Shoenfeld, Y. and Rose, N. (Eds) Elsevier B.V. pp.689–692.

  3. Reif S, Lerner A (2004) Tissue transglutaminase—the key player in celiac disease: a review. Autoimm Rev 3:40–45

    Article  CAS  Google Scholar 

  4. Shamir R, Eliakim R, Lahat N, Sobel E, Lerner A (2002) ELISA assay of anti endomysial antibodies in the diagnosis of celiac disease: comparison with immunofluorescence assay of anti endomysial antibodies and tissue transglutaminase antibodies. Isr Med Assoc J 4:594–596

    PubMed  CAS  Google Scholar 

  5. Rozenberg O, Lerner A, Pacht A, Grinberg M, Reginashvili D, Henig C, Barak M (2010) A novel algorithm for childhood celiac disease serological diagnosis based upon intestinal biopsies. Crit Rev Allerg Immunol (in press)

  6. Lerner A (2010) New therapeutic strategies for celiac disease. Autoimmun Rev 9:144–147

    Article  PubMed  CAS  Google Scholar 

  7. Lerner A (1994) Factors affecting the clinical presentation and time diagnosis of celiac disease: the Jerusalem and the West Bank-Gaza experience (editorial). Isr J Med Sci 30:294–295

    PubMed  CAS  Google Scholar 

  8. Branski D, Ashkenazy A, Frier S, Lerner A et al (1992) Extra intestinal manifestation and associated disorders of celiac disease. In: Branski D, Rozen P, Kaganoff MF (eds) Gluten-sensitive enteropathy from gastrointest res. Karger, Basel, pp 164–175

    Google Scholar 

  9. Zelnik N, Pacht A, Obeid R, Lerner A (2004) Range of neurological disorders in patients with celiac disease. Pediatrics 113:1672–1676

    Article  PubMed  Google Scholar 

  10. Lerner A, Makhoul B, Eliakim (2010) Neurological manifestations of celiac disease in children and adults. Eur Neurolog J (in press)

  11. Capriles VD, Martini LA, Arêas JA (2009) Metabolic osteopathy in celiac disease: importance of a gluten-free diet. Nutr Rev 67:599–606

    Article  PubMed  Google Scholar 

  12. Zanchi C, Di Leo G, Ronfani L, Martelossi S, Not T, Ventura A (2008) Bone metabolism in celiac disease. J Pediatr 153:262–265

    Article  PubMed  CAS  Google Scholar 

  13. Bianchi ML, Bardella MT (2008) Bone in celiac disease. Osteoporos Int 19:1705–1716

    Article  PubMed  Google Scholar 

  14. Scott EM, Gaywood I, Scott BB (2000) Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut 46(Suppl 1):1–8

    Article  Google Scholar 

  15. Turner J, Pellerin G, Mager D (2009) Prevalence of metabolic bone disease in children with celiac disease is independent of symptoms at diagnosis. J Pediatr Gastroenterol Nutr 49:589–593

    Article  PubMed  Google Scholar 

  16. Lewis NR, Scott BB (2005) Should patients with coeliac disease have their bone mineral density measured? Eur J Gastroenterol Hepatol 17:1065–1070

    Article  PubMed  Google Scholar 

  17. Mora S (2008) Celiac disease in children: impact on bone health. Rev Endocr Metab Disord 9:123–130

    Article  PubMed  Google Scholar 

  18. Olmos M, Antelo M, Vazquez H, Smecuol E, Mauriño E, Bai JC (2008) Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis 40:46–53

    Article  PubMed  CAS  Google Scholar 

  19. Shoenfeld N, Amital H, Shoenfeld Y (2009) The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol 5:99–105

    Article  PubMed  CAS  Google Scholar 

  20. Albert PJ, Proal AD, Marshall TG (2009) Vitamin D: the alternative hypothesis. Autoimmun Rev 8:639–644

    Article  PubMed  CAS  Google Scholar 

  21. Toubi E, Shoenfeld S (2010) The role of vitamin D in regulating immune responses. IMAJ 12:174–175

    PubMed  Google Scholar 

  22. Pappa H, Gordon C, Saslowsky T et al (2006) Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118:1950–1961

    Article  PubMed  Google Scholar 

  23. Nieves J, Cosman F, Herbert J, Shen V, Lindsay R (1994) High prevalence of vitamin-D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687–1692

    Article  PubMed  CAS  Google Scholar 

  24. Aguado P, del Campo M, Garces M et al (2000) Low vitamin-D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int 11:739–744

    Article  PubMed  CAS  Google Scholar 

  25. Kamen D, Cooper G, Bouali H et al (2006) Vitamin-D deficiency in systemic lupus erythematosus. Autoimmun Rev 5:114–117

    Article  PubMed  CAS  Google Scholar 

  26. Di Cesar D, Ploutz-Snyder R, Weinstock R, Moses A (2006) Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diab Care 29:174

    Article  Google Scholar 

  27. Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin-D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66:1137–1142

    Article  PubMed  CAS  Google Scholar 

  28. Orbach H, Zandman-Goddard G, Amital H, Barak V et al (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin-D, and TPA levels in autoimmune diseases. Ann NY Acad Sci 1109:385–400

    Article  PubMed  CAS  Google Scholar 

  29. Munger K, Levin L, Hollis B, Howard N, Ascherio A (2006) Serum 25-hydroxyvitamin-D levels and risk of multiple sclerosis. JAMA 296:2832–2838

    Article  PubMed  CAS  Google Scholar 

  30. Hewison M (2010) Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin N Am 39:365–379

    Article  CAS  Google Scholar 

  31. Pelajo CF, Lopez-Benitez JM, Miller LC (2010) Vitamin D and autoimmune rheumatologic disorders. Autoimmune Rev 9:507–510

    Article  CAS  Google Scholar 

  32. Shapira Y, Agmon-levin N, Shoenfeld Y (2010) Mycobacterium tuberculosis, autoimmunity, and vitamin D. Clin Rev Allerg Immunol 38:169–177

    Article  CAS  Google Scholar 

  33. Holick MF (2010) Vitamin D: extraskeletal health. Endocrinol Metab Clin N Am 39:381–400

    Article  CAS  Google Scholar 

  34. Chen S, Sims GP, Chen X et al (2007) Modulatory effects of 1, 25-dihydroxyvitamin-D3 on human B cell differentiation. J Immunol 179:1634–1647

    PubMed  CAS  Google Scholar 

  35. van Etten E, Mathieu C (2005) Immunoregulation by 1, 25-dihydroxyvitamin-D3: basic concepts. J Steroid Biochem Mol Biol 97:93–101

    Article  PubMed  Google Scholar 

  36. Overbergh L, Decallonne B, Waer M et al (2000) 1alpha, 25-dihydroxyvitamin-D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p 524–543). Diabetes 49:1301–1307

    Article  PubMed  CAS  Google Scholar 

  37. Bhalla A, Amento E, Serog B, Glimcher L (1984) 1, 25-Dihydroxyvitamin-D3 inhibits antigen-induced T cell activation. J Immunol 133:1748–1754

    PubMed  CAS  Google Scholar 

  38. Lemire J (1992) Immunomodulatory role of 1, 25-dihydroxyvitamin-D3. J Cell Biochem 49:26–31

    Article  PubMed  CAS  Google Scholar 

  39. Lemire JM, Archer D, Beck L, Spiegelberg H (1995) Immunosuppressive actions of 1, 25-dihydroxyvitamin-D3: preferential inhibition of Th1 functions. J Nutr 125:1704S–1708S

    PubMed  CAS  Google Scholar 

  40. Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B (2007) Vitamin D in rheumatoid arthritis. Autoimmun Rev 7:59–64

    Article  PubMed  CAS  Google Scholar 

  41. Penna G, Amuchastegui S, Cossetti C et al (2006) Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin-D receptor agonist elocalcitol. J Immunol 177:8504–8511

    PubMed  CAS  Google Scholar 

  42. Penna G, Adorini L (2000) 1α, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405–2411

    PubMed  CAS  Google Scholar 

  43. Adorini L, Giarratana N, Penna G (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 16:127–134

    Article  PubMed  CAS  Google Scholar 

  44. Luciano A, Giuseppe P (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4:404–412

    Article  Google Scholar 

  45. Daniel C, Schlauch T, Zugel U, Steinmeyer A et al (2005) 22-ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities. Eur J Clin Invest 35:343–349

    Article  PubMed  CAS  Google Scholar 

  46. Carvalho JF, Blank M, Kiss E, Tarr T, Amital H, Shoenfeld Y (2007) Anti-vitamin-D, vitamin-D in SLE: preliminary results. Ann NY Acad Sci 1109:550–557

    Article  PubMed  CAS  Google Scholar 

  47. Ramos-Lopez E, Jansen T, Ivaskevicius V et al (2006) Protection from type 1 diabetes by vitamin-D receptor haplotypes. Ann NY Acad Sci 1079:327–334

    Article  PubMed  CAS  Google Scholar 

  48. Rudko AA, Kondrateva EI, Iankina GN, Loshkova EV, Puzyrev VP (2008) Influence of polymorphism of immune defense modifier genes on celiac disease development and various clinical features of disease in Tomsk population. Mol Biol Mosk 42:42–49

    PubMed  CAS  Google Scholar 

  49. San-Pedro JI, Bilbao JR, Perez de nanclares G, Vitoria JC, Martul P, Castano L (2005) Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus. Autoimmunity 38:439–444

    Article  PubMed  CAS  Google Scholar 

  50. Bailey R, Cooper J, Zeitels L et al (2007) Association of the vitamin-D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56:2616–2621

    Article  PubMed  CAS  Google Scholar 

  51. Huang C, Wu M, Wu J, Tsai F (2002) Association of vitamin-D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 11:31–34

    Article  PubMed  CAS  Google Scholar 

  52. Shimada A, Kanazawa Y, Motohashi Y et al (2008) Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmun 30:207–211

    Article  PubMed  CAS  Google Scholar 

  53. Abe J, Nakamura K, Takita Y, Nakano T, Irie H, Nishii Y (1990) Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha, 25-dihydroxyvitamin-D3. J Nutr Sci Vitaminol 36:21–31

    Article  PubMed  CAS  Google Scholar 

  54. Daniel C, Radeke H, Sartory N et al (2006) The new low calcemic vitamin-D analog 22-ene-25-oxa-vitamin-D prominently ameliorates Th1-mediated colitis in mice. J Pharmacol Exp Ther 319:622–631

    Article  PubMed  CAS  Google Scholar 

  55. Cantorna M, Hayes C, DeLuca H (1996) 1, 25-Dihydroxyvitamin-D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93:7861–8764

    Article  PubMed  CAS  Google Scholar 

  56. Cantorna M, Humpal-Winter J, DeLuca H (1999) Dietary calcium is a major factor in 1, 25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J Nutr 129:1966–1971

    PubMed  CAS  Google Scholar 

  57. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R (1994) Prevention of autoimmune diabetes in NOD mice by 1, 25 dihydroxyvitamin-D3. Diabetologia 37:552–558

    Article  PubMed  CAS  Google Scholar 

  58. Munger K, Zhang S, O'Reilly E et al (2004) Vitamin-D intake and incidence of multiple sclerosis. Neurology 62:60–65

    Article  PubMed  CAS  Google Scholar 

  59. Goldberg P, Fleming M, Picard E (1986) Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin-D. Med Hypotheses 21:193–200

    Article  PubMed  CAS  Google Scholar 

  60. Merlino L, Curtis J, Mikuls T et al (2004) Vitamin-D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50:72–77

    Article  PubMed  CAS  Google Scholar 

  61. Birlea S, Costin G, Norris D (2008) Cellular and molecular mechanisms involved in the action of vitamin-D analogs targeting vitiligo depigmentation. Curr Drug Targets 9:345–359

    Article  PubMed  CAS  Google Scholar 

  62. Holick M (2007) Vitamin D deficiency. N Engl J Med 357:266–281

    Article  PubMed  CAS  Google Scholar 

  63. Correale J, Ysrraelit MC, Gaitan MI (2009) Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132:1146–1160

    Article  PubMed  Google Scholar 

  64. Adorini L, Penna G (2009) Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb Exp Pharmacol 188:251–273

    Article  PubMed  CAS  Google Scholar 

  65. Ginde AA, Liu MC, Camargo CA Jr (2009) Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med 169:626–632

    Article  PubMed  CAS  Google Scholar 

  66. Pignotti GAP, Genaro PS, Pinheiro MM, Szejnfeld VL, Martini LA (2009) Is a lower dose of vitamin D supplementation enough to increase 25(OH)D status in a sunny country? Eur J Nutr 49:277–283

    Article  PubMed  Google Scholar 

  67. Mansbach JM, Ginde AA, Camargo CA Jr (2009) Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D? Pediatrics 124:1404–1410

    Article  PubMed  Google Scholar 

  68. Gannage-Yared MH, Chemali R, Yaacoub N, Halaby G (2000) Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res 15:1856–1862

    Google Scholar 

  69. Mishal AA (2001) Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Osteoporos Int 12:931–935

    Article  PubMed  CAS  Google Scholar 

  70. Kimlin M, Harrison S, Nowak M, Moore M, Brodie A, Lang C (2007) Does a high UV environment ensure adequate vitamin D status? J Photochem Photobiol B 89:139–147

    Article  PubMed  CAS  Google Scholar 

  71. Holick MF (2008) Deficiency of sunlight and vitamin D. BMJ 336:1318–1319

    Article  PubMed  Google Scholar 

  72. Bischoff-Ferrari H (2009) Vitamin D: what is an adequate vitamin D level and how much supplementation is necessary? Best Pract Res Clin Rheumatol 23:789–795

    Article  PubMed  CAS  Google Scholar 

  73. Mithal A, Wahl DA, Bonjour JP, Burckhardt P et al (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20:1807–1820

    Article  PubMed  CAS  Google Scholar 

  74. Oren Y, Shapira Y, Agmon-Levin N, Kivity S, Zafrir Y, Altman A, Lerner A, Shoenfeld Y (2010) Vitamin D insufficiency in a sunny environment: a demographic and seasonal analysis. IMAJ 12:2–7

    Google Scholar 

  75. Walters JR (2003) The role of the intestine in bone homeostasis. Eur J Gastroenterol Hepatol 15:845–849

    Article  PubMed  CAS  Google Scholar 

  76. Bernstein CN, Leslie WD (2003) The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol 15:857–864

    Article  PubMed  CAS  Google Scholar 

  77. Vestergaard P (2003) Bone loss associated with gastrointestinal disease; prevalence and pathogenesis. Eur J Gastroenterol Hepatol 15:851–856

    Article  PubMed  Google Scholar 

  78. Stenson WF, Newberry R, Lorenz R, Baldus C, Civitelli R (2005) Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med 28:393–399

    Article  Google Scholar 

  79. Legroux-gerot I, Leloire O, Blanckaert F, Tonnel F et al (2009) Screening for celiac disease in patients with osteoporosis. Joint Bone Spine 76:162–165

    Article  PubMed  Google Scholar 

  80. Stazi AV, Trecca A, Trinti B (2008) Osteoporosis in celiac disease and in endocrine and reproductive disorders. World J Gastroenterol 28:498–505

    Article  Google Scholar 

  81. Capriles VD, Martini LA, Areas JA (2009) Metabolic osteopathy in celiac disease: importance of gluten-free diet. Nutr Rev 67:599–606

    Article  PubMed  Google Scholar 

  82. Hartman C, Hino B, Lerner A et al (2004) Bone quantitative ultrasound and bone mineral density in children with celiac disease. J Pediatr Gastrointerol Nutr 39:504–510

    Article  Google Scholar 

  83. Walker-Smith JA, Guandalini S, Schmitz J et al (1990) Revised criteria for the diagnosis of celiac disease. Report of the working group of European Society of Pediatric Gastroenterology and Nutrition. Arch Dis Child 65:909–911

    Article  Google Scholar 

  84. Levis S, Gomez A, Jimenez C et al (2005) Vitamin D deficiency and seasonal variation in an adult South Florida population. J Clin Endocrinol Metab 90:1557–1562

    Article  PubMed  CAS  Google Scholar 

  85. Saintonge S, Bang H, Gerber LM (2009) Implication of a new definition of vitamin D deficiency in a multiracial US adolescent population: the national health and nutrition examination survey III. Pediatrics 123:797–803

    Article  PubMed  Google Scholar 

  86. Hirani V, Tull K, Ali A, Mindell J (2010) Urgent action needed to improve vitamin D status among older people in England! Age Ageing 39:62–68

    Article  PubMed  Google Scholar 

  87. Lagunova Z, Porojnicu AC, Lindberg F et al (2009) The dependency of vitamin D status on body mass index, gender, age, and season. Anticancer Res 29:3713–3720

    PubMed  CAS  Google Scholar 

  88. Kinsey L, Burden ST, Bannerman E (2008) A dietary survey to determine if patients with celiac disease are meeting current healthy eating guidelines and how their diet compared to that of the British general population. Eur J Clin Nutr 62:1333–1342

    Article  PubMed  CAS  Google Scholar 

  89. Colston KW, Mackay AG, Finlayson C et al (1994) Localization of vitamin D receptor in normal human duodenum and in patients with coeliac disease. Gut 35:1219–1225

    Article  PubMed  CAS  Google Scholar 

  90. Rossi TM, Kumar V, Lerner A, Heitlinger LA, Tucker N, Fisher J (1988) Relationship of endomysial antibodies to jejunal mucosa pathology: specificity towards both symptomatic and asymptomatic celiacs. J Pediatr Gastroenterol Nutr 7:858–863

    Article  PubMed  CAS  Google Scholar 

  91. Yanbin D, Polloc N, Stallmann-Jorgensen IS et al (2010) Low 25-hydroxyvitamin D levels in adolescents: race, season, adiposity, physical activity, and fitness. Pediatrics 125:1104–1111

    Article  Google Scholar 

  92. Toh SY, Zarshenas N, Jorgensen J (2009) Prevalence of nutrient deficiencies in bariatric patients. Nutrition 25:1150–1156

    Article  PubMed  CAS  Google Scholar 

  93. Nilas L, Christiansen C (1987) Vitamin D deficiency after selective vagotomy. Acta Med Scand 221:303–306

    Article  PubMed  CAS  Google Scholar 

  94. D’Elios MM, Amedel A, Benagiano M et al (2005) Helicobacter pylori, T cells, and cytokines: the “dangerous liaisons”. FEMS Immunol Med Microbiol 44:113–119

    Article  PubMed  Google Scholar 

  95. Hosseini ME, Oghalaie A, Habibi G et al (2010) Molecular detection of host cytokine expression in Helicobacter pylori infected patients via semi-quantitative RT-PCR. Indian J Med Microbiol 28:40–44

    Article  PubMed  Google Scholar 

  96. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y et al (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9:709–715

    Google Scholar 

  97. Mimouni FB (2010) Vitamin D status in growing children: Should we routinely screen for vitamin D adequacy. J Pediatr Gastroenterol Nutr 51:S121–S122

    Google Scholar 

  98. Hill ID, Dirks MH, Liptak GS et al (2005) Guidelines for the diagnosis and treatment of celiac disease in children: recommendation of the North American society for pediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr 40:1–19

    Article  PubMed  Google Scholar 

  99. Kupper C (2005) Dietary guidelines and implementation for celiac disease. Gastroenterology 128:s121–s127

    Article  PubMed  CAS  Google Scholar 

  100. Blazina S, Bratanic N, Campa AS, Blagus R, Orel R (2010) Bone mineral density and importance of strict gluten-free diet in children and adolescents with celiac disease. Bone 47:598–603

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

To Mrs. Lavi Idit, Department of Epidemiology, Statistic Section, Carmel Medical Center, for her excellent statistic workup and constructive advices.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aaron Lerner.

Additional information

Aaron Lerner and Yinon Shapira contributed equally to this article.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lerner, A., Shapira, Y., Agmon-Levin, N. et al. The Clinical Significance of 25OH-Vitamin D Status in Celiac Disease. Clinic Rev Allerg Immunol 42, 322–330 (2012). https://doi.org/10.1007/s12016-010-8237-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-010-8237-8

Keywords

Navigation